Title  |
Author |
Type |
Words |
| A.O. Smith initiated with a Neutral at Rosenblatt. |
|
|
115 |
| Acceleron announces updated results from Phase 3 luspatercept trial. |
|
|
174 |
| Acceleron reports Q3 EPS (86c), consensus (82c). |
|
Financial report |
156 |
| Actinium Pharma's Actimab-A CLAG-M combination shows 83% remission in AML. |
|
|
159 |
| Activision insiders sold shares after buyback news, Washington Post reports. |
|
|
135 |
| Adaptimmune reports Q3 EPS (6c), consensus (31c). |
|
Financial report |
110 |
| Adaptimmune sees cash, cash equivalents funding operations through 3Q20. |
|
|
216 |
| ADMA Biologics reports Q3 EPS (19c), consensus (23c). |
|
Financial report |
142 |
| AES Corp. entering 10-year strategic alliance with Google. |
|
|
206 |
| Aimmune reports Q3 EPS ($1.03), consensus ($1.03). |
|
Financial report |
177 |
| Air Transport Services backs FY19 adjusted EBITDA view of $450M. |
|
|
180 |
| Airbus agrees to ramp up production in China. |
|
|
242 |
| Aircastle to be acquired for $32 per share in cash. |
|
|
251 |
| Altice USA removed from Analyst Focus List at JPMorgan. |
|
|
108 |
| Amazon announces Amazon Robotics innovation hub in MA, plans to create 200 jobs. |
|
|
133 |
| American Equity reports Q3 adjusted EPS $2.54, consensus 99c. |
|
Financial report |
118 |
| Amneal Pharmaceuticals cuts FY19 adj. EPS view to about 31c from 52c-62c. |
|
|
141 |
| Amneal Pharmaceuticals enters licensing agreement with Kashiv BioSciences. |
|
|
127 |
| Anavex announces publication of foundational data for ANAVEX 2-73. |
|
|
217 |
| Antengene announces exclusive worldwide license from AstraZeneca for AZD0364. |
|
|
173 |
| Arcos Dorados furthers transition to serving cage free eggs in Brazil. |
|
|
113 |
| Arena Pharmaceuticals' etrasimod shows favorable PK properties in study. |
|
|
170 |
| ArQule data for ARQ 531 'continue to look strong,' says SVB Leerink. |
|
|
115 |
| Asian Market Wrap:. |
|
|
263 |
| ASML delaying key tech delivery to China amid U.S. scrutiny, Nikkei reports. |
|
|
128 |
| Aspen Group promotes Anne McNamara to chief nursing officer. |
|
|
155 |
| Assertio Therapeutics reports Q3 EPS 24c, consensus 24c. |
|
Financial report |
139 |
| AstraZeneca backs $1B China biotech fund for smaller ventures. |
|
|
252 |
| AstraZeneca says Calquence Phase 3 data show improved PFS in CLL patients. |
|
|
144 |
| Atara Biotherapeutics to present Tab-cel long-term clinical outcomes. |
|
|
282 |
| Avanos shares could be range-bound over next six months, says Raymond James. |
|
|
127 |
| Avantor, NIBRT team to address buffer preparation efficiency when producing mAbs. |
|
|
142 |
| AXA Equitable announces $400M share repurchase authorization. |
|
|
112 |
| Axcella enrolls first patient in AXA4010-001 study for SCD. |
|
Clinical report |
193 |
| AxoGen reports Q3 EPS (14c), consensus (11c). |
|
Financial report |
138 |
| Azul reports October traffic up 36.3%. |
|
|
121 |
| Baidu reports Q3 DAUs reached 189M, up 25% y/y. |
|
|
161 |
| Barclays downgrades Altice USA, says guidance raises visibility questions. |
|
|
141 |
| Barrick Gold reports Q3 adj. EPS 15c, consensus 11c. |
|
|
241 |
| Bellerophon reports Q3 EPS (6c), consensus (7c). |
|
Financial report |
246 |
| Bio-Techne licenses aTAG Technology from C4 Therapeutics. |
|
|
167 |
| Biogen announces transaction with Samsung Bioepis for rights to two biosimilars. |
|
|
445 |
| Biogen enters commercialization agreement with Samsung Bioepis for SB11, SB15. |
|
|
136 |
| Blackstone CEO optimistic U.S., China will resolve trade war, Reuters says. |
|
|
107 |
| Bloomin' Brands jumps as company explores strategic alternatives. |
|
|
388 |
| Bloomin' Brands reports Q3 adj. EPS 10c, consensus 10c. |
|
Financial report |
171 |
| Blueprint Medicines upgraded to Strong Buy at Raymond James. |
|
|
102 |
| Brooks Automation reports Q4 non-GAAP EPS 24c, consensus 23c. |
|
Financial report |
115 |
| BRT Apartments reports Q3 EPS 20c, consensus 21c. |
|
Financial report |
163 |
| California AG petitions court to force Facebook to comply with subpoena. |
|
|
168 |
| Call buyers go on a $26M spending spree in Emerging Markets ETF. |
|
|
215 |
| capri Holdings reports Q2 adjusted EPS $1.16, consensus $1.24. |
|
Financial report |
103 |
| Carrizo Oil & Gas shareholder votes against acquisition by Callon Petroleum. |
|
|
163 |
| Cars.com's Q3 revenue beats estimates, FY19 guidance is maintained. |
|
Financial report |
360 |
| Casella Waste announces remarketing of $25M of revenue bonds. |
|
|
227 |
| CBRE Group reports Q3 adjusted EPS 79c, consensus 78c. |
|
Financial report |
142 |
| Cedar Fair reports Q3 EPS $3.34, consensus $3.44. |
|
Financial report |
487 |
| Cellectis reports Q3 adjusted EPS (23c), consensus (80c). |
|
Financial report |
187 |
| Charles River reports Q3 EPS $1.69, consensus $1.63. |
|
Financial report |
112 |
| CNH Industrial announces departure of CTO Alan Berger. |
|
|
115 |
| Columbus McKinnon plans closure of Ohio operation. |
|
|
169 |
| Conduent reports Q3 adjusted EPS 16c, consensus 15c. |
|
Financial report |
107 |
| Constellation Pharmaceuticals reports Q3 EPS (82c), consensus (83c). |
|
Financial report |
140 |
| Constellation Pharmaceuticals reports Q3 EPS (82c), consensus (83c). |
|
Financial report |
140 |
| Constellation soars 110% after reporting new data from myelofibrosis trial. |
|
|
210 |
| Cool Holdings announces delisting from Nasdaq, to trade on OTCQB. |
|
|
338 |
| CPI Card Group reports Q3 EPS (6c), consensus 3c. |
|
Financial report |
145 |
| Cubic awarded $325M contract from U.S. Marine Corps. |
|
|
155 |
| CVS Health CEO: All core businesses performed in line with or above expectations. |
|
|
169 |
| CVS Health says expects 1,500 health hubs by end of 2021. |
|
|
112 |
| Devon Energy, QLCP partner to fund Delaware Basin gas gathering infrastructure. |
|
|
155 |
| Diversified Restaurant to be acquired by ICV Partners for ~ $130M in cash. |
|
|
230 |
| Eldorado Resorts CEO says 'increasingly excited' about Caesars acquisition. |
|
|
105 |
| Endologix reports Q3 EPS (40c), consensus (72c). |
|
Financial report |
154 |
| EnerSys sees Q3 EPS $1.12-$1.16, consensus $1.32. |
|
Financial report |
105 |
| ePlus reports Q2 EPS $1.51, consensus $1.39. |
|
Financial report |
127 |
| Esperion reports Q3 EPS ($2.52), consensus ($1.95). |
|
|
112 |
| Evogene subsidiary Canonic initiates cultivation of medical cannabis varieties. |
|
|
121 |
| eXp World Holdings reports Q3 EPS (3c), consensus (5c). |
|
Financial report |
114 |
| Exxon Mobil, FuelCell expand agreement for carbon capture technology. |
|
|
152 |
| Facebook being probed by California for privacy violations, Reuters reports. |
|
|
104 |
| Facebook exec says Zuckerberg not giving up on Libra, BI reports. |
|
|
104 |
| Fed funds futures are moderately firmer. |
|
|
162 |
| Fed's Williams said the FOMC moved policy to a slightly accommodative stance. |
|
|
114 |
| Federal Agricultural Mortgage reports Q3 core EPS 2.17, consensus $2.20. |
|
Financial report |
124 |
| Fitbit reports Q3 adjusted EPS (10c), consensus (10c). |
|
|
116 |
| Fly Intel: Pre-market Movers. |
|
|
179 |
| Fly Intel: Top five analyst downgrades. |
|
|
234 |
| Fly Intel: Top five analyst initiations. |
|
|
109 |
| Fly Intel: Top five analyst upgrades. |
|
|
236 |
| Fly Intel: What to watch in Square earnings report. |
|
|
425 |
| ForeScout reports Q3 EPS (2c), consensus (1c). |
|
Financial report |
125 |
| Fox Corp. announces $2B stock repurchase program. |
|
|
280 |
| Fox Corp. reports Q1 adjusted EPS 83c, consensus 69c. |
|
Financial report |
200 |
| FuelCell announces $200M strategic corporate loan facility with Orion Energy. |
|
|
229 |
| FX Action: The dollar and other currencies have been lacking direction. |
|
|
257 |
| FX Action: The yen. |
|
|
176 |
| FX Action: USD-CAD has settled in the mid 1.3100s. |
|
|
111 |
| FX Action: USD-CAD. |
|
|
113 |
| FX Update: The dollar has been consolidating gains. |
|
|
215 |
| GasLog reports Q3 adjusted EPS 1c, consensus 8c. |
|
Financial report |
324 |
| GenMark reports Q3 EPS (20c), consensus (19c). |
|
Financial report |
109 |
| Giga-tronics to effect one-for-fifteen reverse stock split. |
|
|
182 |
| Gilead presents data supporting non-inferior efficacy of Descovy for PrEP. |
|
|
318 |
| Gladstone Land reports Q EPS (3c), consensus (4c). |
|
Financial report |
213 |
| Global Blood Therapeutics announces data presentations at ASH annual meeting. |
|
|
530 |
| Globus Medical reports Q3 EPS 43c, consensus 42c. |
|
|
125 |
| Glu Mobile reports Q3 EPS (3c), consensus 3c. |
|
Financial report |
112 |
| Guggenheim downgrades CenturyLink to Sell with unchanged $10 target. |
|
|
144 |
| Horizon Pharma reports Q3 EPS 64c, consensus 49c. |
|
Financial report |
121 |
| Hostess Brands reports Q3 adjusted EPS 13c, consensus 12c. |
|
|
143 |
| Hostess Brands sees 2019 adjusted EBITDA $202M-$208M. |
|
|
103 |
| HP Inc. confirms receiving proposal from Xerox. |
|
|
127 |
| IBM, Bank of America team up to launch financial services-ready public cloud. |
|
|
215 |
| ICF International reports Q3 non-GAAP EPS $1.12, consensus $1.08. |
|
Financial report |
133 |
| iFresh terminates Xiaotai share exchange agreement, to explore other options. |
|
|
111 |
| Immersion reports Q3 EPS 0c, consensus 5c. |
|
Financial report |
118 |
| Information Services reports Q3 non-GAAP EPS 9c, consensus 7c. |
|
Financial report |
109 |
| Insight Enterprises reports Q3 adj. EPS $1.10, consensus $1.07. |
|
|
126 |
| International Flavors price target raised to $140 from $125 at JPMorgan. |
|
|
116 |
| Internet Gold receives notice letter from Searchlight. |
|
|
176 |
| Invacare reports Q3 adjusted EPS (15c), consensus (20c). |
|
Financial report |
109 |
| iQIYI reports Q3 EPS (70c), consensus (72c). |
|
Financial report |
121 |
| James River Group reports Q3 EPS (73c), consensus (93c). |
|
Financial report |
123 |
| Kinross Gold reports Q3 EPS 8c, consensus 8c. |
|
Financial report |
146 |
| Kirkland Lake Gold increased common dividend 50% to 6c per share. |
|
|
287 |
| Kroger, TrueCar partner for Auto Buying Program. |
|
|
192 |
| Lannett reports Q1 adjusted EPS 22c, consensus 19c. |
|
Financial report |
127 |
| Laureate Education reports Q3 EPS (43c), may not compare to consensus 7c. |
|
Financial report |
141 |
| Liberty Global reports Q3 cont ops revenue $2.84B, consennsus $2.84B. |
|
Financial report |
126 |
| Live Ventures to acquire Lonesome Oak Trading, terms not disclosed. |
|
|
123 |
| LiveRamp reports Q2 EPS (23c), consensus (29c). |
|
Financial report |
141 |
| Lockheed Martin awarded $184.58M Navy contract modification. |
|
|
173 |
| Lufthansa cabin crew strike set to start Thursday, Reuters says. |
|
|
108 |
| Lumber Liquidators reports Q3 adj. EPS 8c, consensus 23c. |
|
Financial report |
265 |
| Madison Square Garden higher after Blue Harbour says shares worth $400. |
|
|
133 |
| ManTech wins $132M U.S. Army award for DCGS-A. |
|
|
104 |
| Match Group shares will find floor around $52, says Jefferies. |
|
|
111 |
| Mattel 'buried' accounting issues related to value of Thomas & Frineds, WSJ says. |
|
|
168 |
| MBIA reports Q3 adjusted EPS $1.46 vs. (35c) last year. |
|
Financial report |
186 |
| MDU Resources subsidiary receives permit for Texas quarry operations. |
|
|
126 |
| Meridian Bioscience submits Curian analyzer, Curian HpSA assay to FDA. |
|
|
158 |
| Mesa Labs reports Q2 EPS 71c, consensus 81c. |
|
Financial report |
156 |
| Mizuho backs Buy rating on Fate Therapeutics after competitor downgrade. |
|
|
111 |
| Moderna reports Q3 revenue $17.05M, consensus $18.36M. |
|
Financial report |
166 |
| Morgan Stanley a buyer of GW Pharmaceuticals on any post-earnings weakness. |
|
|
113 |
| Morgan Stanley lays out 'path to $6 billion' for Palo Alto Networks. |
|
|
121 |
| Moxian signs letter of intent with Beijing Bi Er Culture Communication. |
|
|
141 |
| MTBC, Inc reports Q3 adj. EPS 18c, consensus (12c). |
|
Financial report |
220 |
| Myriad Genetics announces publication of analysis of GUIDED trial. |
|
|
277 |
| Nano Dimension regains compliance with Nasdaq. |
|
|
187 |
| National Energy Services reports Q3 adj. EPS 19c, consensus 20c. |
|
Financial report |
253 |
| Nektar reports Q3 EPS (56c), consensus (73c). |
|
Financial report |
168 |
| New York Times reports Q3 adjusted EPS 12c, consensus 10c. |
|
Financial report |
317 |
| New York Times sees Q4 subscription revenues up low-to mid-single digits percent. |
|
Financial report |
171 |
| Nvidia posts 'fastest results' on new AI inference benchmarks. |
|
|
209 |
| Ocugen falls 7% after announcing warrant restructuring. |
|
|
156 |
| Office Depot announces review of potential holding company reorganization. |
|
|
242 |
| Oil majors fall after EIA report shows crude inventory build. |
|
|
153 |
| Oil-Dri Corporation of America opens second research facility. |
|
|
119 |
| Oncolytics announces results from Phase 1b REO 024 study published. |
|
|
124 |
| Orchard Therapeutics to present registrational data on gene therapies. |
|
|
662 |
| Orion Energy reports Q2 EPS 22c, consensus 9c. |
|
Financial report |
484 |
| Papa John's announces new, streamlined senior management team. |
|
|
321 |
| Papa John's reports Q3 adj. EPS 21c, consensus 22c. |
|
Financial report |
129 |
| Park Hotels & Resorts reports Q3 adjusted FFO 68c, consensus 68c. |
|
|
155 |
| PennyMac Financial files antitrust lawsuit against Black Knight. |
|
|
312 |
| Penumbra's Indigo Aspiration System trial met primary safety, efficacy endpoints. |
|
Clinical report |
175 |
| Performance Food Group reports Q1 adj. EPS 50c, consensus 36c. |
|
Financial report |
101 |
| Perrigo reports Q3 adj. EPS $1.04, consensus 93c. |
|
Financial report |
130 |
| Phillips 66 expects capital spending decline in 2020, Reuters says. |
|
|
114 |
| Physicians Realty Trust reports Q3 EPS 8c, consensus 7c. |
|
Financial report |
145 |
| Piper cuts GW Pharmaceuticals target to $160 but says selloff overdone. |
|
|
125 |
| Piper says Acceleron luspatercept data 'mixed,' but hit mark in key population. |
|
|
104 |
| Potential deal size in Xerox-HP report gives Wells Fargo 'pause'. |
|
|
108 |
| Progenics clarifies deadline for Velan's consent solicitation. |
|
|
197 |
| ProQR Therapeutics reports Q2 EPS (EUR0.31) vs. (EUR0.18) last year. |
|
Financial report |
150 |
| ProQR Therapeutics reports Q3 EPS (EUR0.31) vs. (EUR0.18) last year. |
|
Financial report |
152 |
| ProQR Therapeutics reports Q3 EPS (EUR0.31) vs. (EUR0.18) last year. |
|
Financial report |
150 |
| Puma Biotechnology reports Q3 adjusted EPS (12c), consensus (71c). |
|
Financial report |
104 |
| Q2 Holdings reports Q3 EPS 5c, consensus 3c. |
|
Financial report |
106 |
| Q2 Holdings sees Q4 revenue $84.4M-$86.4M, consensus $85.93M. |
|
Financial report |
135 |
| Q2 Holdings sees revenue $313M-$315M, consensus $314.15M. |
|
Financial report |
133 |
| Qualcomm sees Q1 EPS 80c-90c, consensus 83c. |
|
Financial report |
166 |
| RealPage reports Q3 adjusted EPS 45c, consensus 45c. |
|
Financial report |
120 |
| RealPage to acquire Buildium. |
|
|
145 |
| Regeneron and Vyriad to co-develop new virus treatments for cancer. |
|
|
226 |
| Rent-A-Center reports Q3 SSS up 4.5%. |
|
|
138 |
| Ring Energy reports Q3 EPS 15c, consensus 12c. |
|
Financial report |
224 |
| Roku sees FY19 revenue at midpoint of $1.106B, consensus $1.1B. |
|
|
136 |
| Royal Gold reports Q1 EPS ex-items 60c, consensus 59c. |
|
Financial report |
164 |
| Sandy Spring Bancorp to acquire Rembert Pendleton Jackson. |
|
|
293 |
| Scotts Miracle-Gro reports Q4 adj. EPS (91c), consensus (86c). |
|
|
121 |
| Sealed Air reports Q3 adj. EPS 64c, consensus 62c. |
|
Financial report |
133 |
| Sellas Life Sciences announces 1-for-50 reverse stock split. |
|
|
426 |
| Sensus Healthcare reports Q3 EPS (4c), consensus (3c). |
|
Financial report |
135 |
| Sentinel Energy announces cancellation of stockholder meeting. |
|
|
311 |
| Sequans signs multi-year non-exclusive license and services agreement. |
|
|
202 |
| SolarEdge reports Q3 EPS $1.21, consensus $1.16. |
|
Financial report |
163 |
| Sonos rallies after DA Davidson calls 'natural acquisition target' for Apple. |
|
|
206 |
| Southcross receives court approval for asset sales. |
|
|
245 |
| SpartanNash reports Q3 adjusted EPS 30c, consensus 38c. |
|
Financial report |
105 |
| State Street, FactSet announce strategic partnership to distribute MediaStats. |
|
|
151 |
| Stifel says most Intercept investors still focused on upcoming OCA updates. |
|
|
102 |
| SunOpta reports Q3 adj. EPS (11c), consensus (11c). |
|
|
159 |
| Taylor Morrison to acquire William Lyon Homes for $21.45/share in cash and stock. |
|
|
295 |
| Technical Preview: Qualcomm ahead of earnings. |
|
|
105 |
| Tecnoglass reports Q3 adjusted EPS 18c, consensus 20c. |
|
Financial report |
169 |
| Telus completes acquisition of ADT Security Services Canada. |
|
|
162 |
| The -0.3% U.S. Q3 productivity contraction rate. |
|
|
231 |
| TherapeuticsMD reports Q3 EPS (13c), consensus (19c). |
|
Financial report |
109 |
| TimkenSteel sees Q4 shipments down approximately 15%. |
|
|
146 |
| Treasury 10-year auction outlook:. |
|
|
197 |
| Treasury Action: yields have richened with some heavy buying coming in. |
|
|
150 |
| Treasury Market Outlook: Treasury yields have drifted lower. |
|
|
259 |
| Treasury Market Summary. |
|
|
121 |
| Trip.com Group TripAdvisor announce strategic partnership. |
|
|
338 |
| U.S. equities are marginally higher. |
|
|
115 |
| U.S. MBA reported mortgage applications dipped -0.1% in the November 1 week. |
|
|
120 |
| U.S. Q3 posted a -0.3% decline in Q3 productivity. |
|
|
146 |
| Uber to allow passengers record audio of rides in Brazil, Mexico, Reuters says. |
|
|
123 |
| UPS announces UPS Simple Rate. |
|
|
102 |
| Upwork reports Q3 EPS 2c, consensus (4c). |
|
Financial report |
118 |
| VBL Therapeutics announces new IND for Phase 2 trial of VB-111 in rGBM. |
|
|
186 |
| Venator Materials reports Q3 adj. EPS 8c, consensus 3c. |
|
Financial report |
177 |
| Veritone reports Q3 EPS (43c), consensus (43c). |
|
Financial report |
108 |
| Visa announces plans for new San Francisco headquarters. |
|
|
157 |
| Vislink receives $3M in new orders. |
|
|
117 |
| Voce Capital says 'abrupt CEO transition does not allay concerns' about Argo. |
|
|
126 |
| Voyager Therapeutics reports Q3 EPS (41c), may not compare to consensus (76c). |
|
Financial report |
129 |
| Vulcan Materials backs FY19 cont ops EPS view $4.55-$5.05, consensus $4.86. |
|
|
114 |
| Vulcan Materials CEO sees 'another year of strong earnings growth' in 2020. |
|
|
208 |
| Wabash reports Q3 EPS 46c, consensus 44c. |
|
Financial report |
101 |
| Walgreens leveraged buyout 'somewhat difficult to envision,' says Citi. |
|
|
143 |
| Walker & Dunlop reports Q3 EPS $1.39, consensus $1.34. |
|
Financial report |
188 |
| Washington Water Service to acquire Rainier View Water, terms not disclosed. |
|
|
108 |
| WW downgraded to Neutral after Q3 miss at DA Davidson. |
|
|
106 |
| Wynn Resorts reports Q3 adjusted EPS 17c, consensus 90c. |
|
Financial report |
130 |
| Xebec Adsorption says Asja in final construction phase of Genoa plant. |
|
|
150 |
| Xencor price target lowered to $44 from $52 at SVB Leerink. |
|
|
104 |
| Xerox considering cash-and-stock takeover offer for HP, WSJ reports. |
|
|
101 |
| Xerox, HP combination 'looks feasible and has merits,' says JPMorgan. |
|
|
141 |
| Zagg reports Q3 EPS 30c, consensus 31c. |
|
Financial report |
242 |
| Zimmer Biomet price target raised to $160 from $155 at SVB Leerink. |
|
|
103 |
| Zynerba reports Q1 EPS (8c), consensus (52c). |
|
Financial report |
129 |
November 6, 2019
